Skip to main content
Hero

Expert insights and radioligand therapy (RLT) resources

Read about how RLT is becoming accessible to more patients

STAT logo. Article sponsored by Novartis

Why geography shouldn’t limit cancer care: The growing reach of RLT

Watch the state-of-the-art manufacturing process behind Novartis RLTs

See the mechanism of action that makes RLT a unique treatment option

Hear from trailblazers in RLT
 

Dr Ghassan El-Haddad: “RLTs are a once-in-a-lifetime breakthrough” in the management of cancer

Dr Calvin Lewis: "In most centers, including mine, [treating with] radioligand therapy is a team-based approach"

Dr Jahan Aghalar: “RLTs have changed the trajectory of how cancer is treated”

Dr Steven Finkelstein: “Radioligand therapy is more than an advancement”

Important investment considerations to start an RLT program